PTC Therapeutics (PTCT) Earnings Date, Estimates & Call Transcripts

$36.92

+1.44 (+4.06%)

(As of 12:51 PM ET)

Upcoming Earnings Date: Oct. 24Estimated
Actual EPS (Aug. 8): -$1.16 Missed By -$0.16
Consensus EPS (Aug. 8): -$1.00

PTCT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PTCT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Monetary Gold

Biden's Executive Order, Dems Digital Money Legislation, First Step To

Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.

This means you must act NOW before it's too late.

PTC Therapeutics Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2024	3	($1.32)	($0.87)	($1.06)
Q2 2024	3	($1.02)	($0.67)	($0.86)
Q3 2024	3	($1.91)	($0.76)	($1.36)
Q4 2024	3	($1.60)	($0.80)	($1.31)
FY 2024	12	($5.85)	($3.10)	($4.59)
Q1 2025	2	($1.32)	($1.22)	($1.27)
Q2 2025	2	($1.22)	($1.01)	($1.12)
Q3 2025	2	($0.91)	($0.77)	($0.84)
Q4 2025	2	($0.90)	($0.69)	($0.80)
FY 2025	8	($4.35)	($3.69)		($4.02)

PTCT Earnings Date and Information

PTC Therapeutics last released its quarterly earnings data on August 8th, 2024. The biopharmaceutical company reported ($1.16) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.00) by $0.16. The company earned $186.70 million during the quarter, compared to analyst estimates of $192.12 million. PTC Therapeutics has generated ($7.68) earnings per share over the last year (($7.68) diluted earnings per share). Earnings for PTC Therapeutics are expected to grow in the coming year, from ($5.09) to ($4.52) per share. PTC Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 24th, 2024 based off prior year's report dates.

PTC Therapeutics Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
10/24/2024 (Estimated)	-	-	-	-	-	-	-
8/8/2024	Q2 2024	($1.00)	($1.16)	($0.16)	($1.03)	$192.12 million	$186.70 million
4/25/2024	Q1 2024	($1.21)	($1.20)	+$0.01	($1.20)	$160.27 million	$210.12 million
2/29/2024	Q4 2023	$0.29	($0.24)	($0.53)	$1.58	$315.90 million	$307.06 million
10/26/2023	Q3 2023	($0.85)	($1.76)	($0.91)	($1.76)	$210.23 million	$196.60 million
8/3/2023	Q2 2023	($1.58)	($2.66)	($1.08)	($2.66)	$206.99 million	$213.80 million
4/27/2023	Q1 2023	($1.64)	($1.88)	($0.24)	($1.88)	$200.48 million	$220.38 million
Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute (Ad) Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it. This means you must act NOW before it's too late.
2/21/2023	Q4 2022	($1.96)	($2.35)	($0.39)	($2.35)	$183.07 million	$167.41 million
10/27/2022	Q3 2022	($1.37)	($1.53)	($0.16)	($1.53)	$194.18 million	$217.13 million
8/4/2022	Q2 2022	($1.67)	($2.13)	($0.46)	($2.13)	$162.53 million	$165.50 million
5/3/2022	Q1 2022	($1.55)	($1.78)	($0.23)	($1.78)	$146.90 million	$148.74 million
2/22/2022	Q4 2021	($1.79)	($2.03)	($0.24)	($2.03)	$161.08 million	$165.20 million
10/28/2021	Q3 2021	($1.78)	($1.89)	($0.11)	($1.89)	$118.87 million	$139.00 million
7/29/2021	Q2 2021	($1.84)	($1.68)	+$0.16	($1.68)	$105.65 million	$116.68 million
5/4/2021	Q1 2021	($1.59)	($1.83)	($0.24)	($1.83)	$98.77 million	$117.94 million
2/25/2021	Q4 2020	($0.90)	($1.08)	($0.18)	($1.08)	$113.47 million	$118.86 million
10/29/2020	Q3 2020	($1.10)	($1.03)	+$0.07	($1.03)	$112.21 million	$82.71 million
8/5/2020	Q2 2020	($1.29)	($2.78)	($1.49)	($2.52)	$82.04 million	$75.24 million
4/30/2020	Q1 2020	($1.00)	($1.81)	($0.81)	($1.79)	$81.90 million	$68.30 million
3/2/2020	Q4 2019	($0.53)	($1.37)	($0.84)	($0.93)	$94.93 million	$96.46 million
10/29/2019	Q3 2019	($0.91)	($1.06)	($0.15)	($0.72)	$72.03 million	$71.40 million

PTC Therapeutics Earnings - Frequently Asked Questions

When is PTC Therapeutics's earnings date?: PTC Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 24th, 2024 based off last year's report dates. Learn more on PTCT's earnings history.
What guidance has PTC Therapeutics issued on next quarter's earnings?: PTC Therapeutics updated its FY 2024 earnings guidance on Thursday, August, 8th. The company issued revenue guidance of $700.0 million-$750.0 million, compared to the consensus revenue estimate of $749.2 million.
Did PTC Therapeutics beat their earnings estimates last quarter?: In the previous quarter, PTC Therapeutics (NASDAQ:PTCT) missed the analysts' consensus estimate of ($1.00) by $0.16 with a reported earnings per share (EPS) of ($1.16). Learn more on analysts' earnings estimate vs. PTCT's actual earnings.
How much revenue does PTC Therapeutics generate each year?: PTC Therapeutics (NASDAQ:PTCT) has a recorded annual revenue of $900.45 million.
How much profit does PTC Therapeutics generate each year?: PTC Therapeutics (NASDAQ:PTCT) has a recorded net income of -$626.60 million. PTCT has generated -$7.68 earnings per share over the last four quarters.
What is PTC Therapeutics's EPS forecast for next year?: PTC Therapeutics's earnings are expected to grow from ($5.09) per share to ($4.52) per share in the next year.